Genprex Strengthens Diabetes Gene Therapy Program with License of Additional Technology from University of Pittsburgh
December 15th, 2022 | 🕒
https://www.ispeech.org/text.to.speech Technology for modulating autoimmunity expands intellectual property portfolio AUSTIN, Texas , Dec. 15, 2022 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company")
Gloss